Show Menu

A fully integrated developer and manufacturer of polyclonal therapeutics, targeting infectious disease and acute toxic events


MicroPharm’s collaborators include:

  • Public Health England – development of treatments for Clostridium difficile infections and Ebola Virus Disease. 
  • University of Leeds - development of a treatment for Clostridium difficile infections.
  • University of Oxford - development of a treatment for Ebola Virus Disease
  • Liverpool School of Tropical Medicine – development of an antivenom for the treatment of envenomation by Echis ocellatus (carpet viper)